Jason Human
Amgen (United States)(US)
Publications by Year
Research Areas
Coagulation, Bradykinin, Polyphosphates, and Angioedema, Coordination Chemistry and Organometallics, Asymmetric Synthesis and Catalysis, Neuropeptides and Animal Physiology, Alzheimer's disease research and treatments
Most-Cited Works
- → Discovery of Aryl Aminoquinazoline Pyridones as Potent, Selective, and Orally Efficacious Inhibitors of Receptor Tyrosine Kinase c-Kit(2008)46 cited
- → Lead Optimization and Modulation of hERG Activity in a Series of Aminooxazoline Xanthene β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors(2014)42 cited
- → Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer’s disease(2015)30 cited
- → Identification of a Nonpeptidic and Conformationally Restricted Bradykinin B1 Receptor Antagonist with Anti-Inflammatory Activity(2007)26 cited
- → Potent Nonpeptide Antagonists of the Bradykinin B1 Receptor: Structure−Activity Relationship Studies with Novel Diaminochroman Carboxamides(2007)26 cited
- → Structure-Based Design of Potent and Selective CK1γ Inhibitors(2012)21 cited
- → Aryl sulfones as novel Bradykinin B1 receptor antagonists for treatment of chronic pain(2008)20 cited
- → Discovery of α-amidosulfones as potent and selective agonists of CB2: Synthesis, SAR, and pharmacokinetic properties(2008)10 cited
- → Chiral lithiothiophenes as non-transferable ligands in organocuprate conjugate addition reactions(2003)9 cited
- → Subtle factors are important: radical formation and transmetallation in reactions of butyl cuprates with cyclohexyl iodide(2005)9 cited